Experts conclude their discussion highlighting key takeaways and considerations when using Janus Kinase (JAK) inhibitors as treatment for atopic dermatitis (AD).
Henry Lim, MD, shares insights on JAK inhibitor safety and the poster presented at the AAD Annual Meeting
Prescribing biologics can require a complex approval and claims process. Creating a tiered system based on office workload can help practices understand and allocate staff time. Outsourcing approvals to pharmacies where possible can also streamline the process.
Expert dermatologists review a final case about a 32-year-old male with AD, highlighting systemic therapy as first-line treatment.
Jack Arbiser, MD, PhD conducted research in a recent study to observe the impact R-propranolol has on broad-spectrum anti-coronavirus activity.
Placental tissues provide a promising alternative for addressing cutaneous reconstruction while maintaining the most cosmetically pleasing outcome.
Epidermolysis bullosa is a broad term used to identify a group of genetic disorders that result in skin blistering and fragility.
Mast spoke with Dermatology Times about her conference workshop, what she's looking forward to ahead of this week's SDPA conference, and the importance of always maintaining a passion for patients.
Patient Cole Villaflor, his mother, and Michael Levy, MD, PhD, provide insights into Cole’s hyperhidrosis diagnosis and subsequent endoscopic thoracic sympathectomy surgery.
Your practice’s finances are the key to long-term business success and understanding them doesn’t have to feel like a puzzle.
Golda explains why he prefers using tranexamic acid to control bleeding in granulated wounds.
Learn what makes the Masterclasses in Dermatology conference a unique educational opportunity, and take a quick poll to tell us what you want to learn.
As we continue to face the COVID-19 pandemic and its long-term consequences, it is more important than ever for providers to build trust with patients.
Several posters presented at the American Academy of Dermatology Annual Meeting explored the topic of skin tone bias related to vitiligo in Google and internet search platforms.
Paul Friedman, MD, discusses the benefits of UltraClear Laser-Coring, patient downtime, how to decide what devices to have in your clinic, and more.
How can you improve excision care for your patients with hidradenitis suppurativa? Ashley Nicole Elsensohn, MD, MPH, FAAD, shared clinical pearls at the AAD Annual Meeting.
Fixed-annuity guarantees more income for penalty-free early withdrawals from retirement plans.
Nitin Joshi, PhD, shared CAGE Bio’s development of CGB-500 and why phase 2 EASI scores have the company’s scientific advisory board optimistic.
Harnessing digital marketing tools can help your medical practice grow.
Sydney Givens, PA-C, reviews how she discusses cosmeceuticals with her patients and what resources she offers.
The paper was authored and issued by the FDA Center for Biologics Evaluation and Research, Center for Drug Evaluation and Research, Center for Devices and Radiological Health, and Office of Combination Products.
Immunotherapy agent nemvaleukin alfa was granted an FDA fast track designation for the treatment of patient’s mucosal melanoma for previously undergone treatment with an anti-PD-L1 therapy.
Founder Dina El-Sherif, MBA, gave an in-depth overview of the at-home facial rejuvenation device and its 3-step process at AAD 2024.
Gold encourages all attendees to feel welcome as they attend both cosmetic and medical dermatology sessions.
In one-third of cases of psoriasis, disease onset occurs in the first or second decade of life, although it may not be diagnosed until the patient has reached adulthood.
Diego Ruiz Dasilva, MD, FAAD, reviews the unmet needs and barriers in the treatment landscape of atopic dermatitis.